Allergan plc (NYSE:AGN) is no longer looking at selling its women’s health business, Allergan plc’s Chief Executive Officer, Brent Saunders said. “For Women’s Health, we have concluded that the highest value proposition for this business at this time is to continue managing it and optimizing it,” Saunders said. Saunders also said the company’s anti-infectives business will “more likely than not” be sold over the near term.